クリエートメディック（5187） – Summary of Financial Results for the first quarter 2022

Document and entity informationDec 2022Mar 2022Company informationCompany informationFASF member markDocument nameFiling dateCompany nameStock exchange listingsTokyoTokyo 1st sectionTokyo 2nd sectionTokyo MothersTokyo JASDAQTokyo PRO MarketTokyo PrimeTokyo StandardTokyo GrowthTokyo OthersNagoyaNagoya PremireNagoya MainNagoya NextNagoya OthersSapporoSapporoSapporo AmbitiousSapporo OthersFukuokaFukuokaFukuoka Q-BoardFukuoka OthersPhoenixSecurities codeURLBusiness categoryGeneral BusinessSpecific BusinessFiscal Year EndQuarterly periodRepresentativeInquiriesTitleNameTitleNameTelOtherJapan Securities Dealers AssociationQuarterly statement filing date (as planned)Supplemental material of quarterly resultsWay of gettingConvening briefing of quarterly resultsTarget for briefing of quarterly resultsNote to fraction processing method2022-05-06CREATE MEDICCO.,LTD.true1truetrue—————————true-2022-12-3151870https://www.createmedic.co.jp1yk{O045-943-26112022-05-11Business Results-Quarterly operating results(in millions of yens)Mar 2022Mar 2021Quarterly operating resultsQuarterly operating resultsConsolidated operating resultsConsolidated income statements informationNet salesNet sales% changeOperating profitOperating profit% changeOrdinary profitOrdinary profit% changeProfit attributable to owners of parentProfit attributable to owners of parent% changeNote to consolidated income statements informationComprehensive incomeComprehensive incomeChange in comprehensive incomeOther consolidated operating resultsBasic earnings per share (Yen)Diluted earnings per share (Yen)Note to consolidated operating resultsNote to operating resultsQuarterly financial positionsQuarterly financial positionsConsolidated financial positionsTotal assetsNet assetsCapital adequacy ratio (%)Net assets per share (Yen)Note to consolidated financial positionsOwner’s equity2,58111.1125158.3165527.51362,928165222132———50544314.5914.96292020 3 311202212118,41314,35978.01,578.8618,07514,22078.71,563.5514,35914,220Business Results-Quarterly financial positions(in millions of yens)Mar 2022Dec 2021Note to financial positions292020 3 3112022121Business Results-Note to quarterly business resultsQuarterly Dividends(in millions of yens)Dec 2022Mar 2022Dec 2021Mar 2022—17.0020.0037.0017.0020.0037.00———–Quarterly note to business resultsQuarterly note to business resultsNote to consolidated financial resultsNote to consolidated financial resultsQuarterly dividendsQuarterly dividendsDividendsDividend per share (Yen)Dividend per share (Yen)First quarterResultSecond quarterThird quarterResultForecastUpperLowerResultForecastUpperLowerResultForecastUpperLowerResultForecastUpperLowerYear endAnnualCorrection of dividend forecast from the most recent dividend forecastCorrection of dividend forecast from the most recent dividend forecastAnnualNote to dividendsNote to dividendsAnnualQuarterly Forecasts(in millions of yens)-Dec 2022Jun 2022Quarterly forecastsQuarterly forecastsTitle for forecastsPreamble to consolidated forecastsPreamble to forecastsMain table of consolidated forecastsNet salesNet sales% changeOperating profitOperating profit% changeOrdinary profitOrdinary profit% changeForecastUpperLowerForecastUpperLowerForecastUpperLowerForecastUpperLowerForecastUpperLowerForecastUpperLowerForecastUpperLowerForecastUpperLowerForecastUpperLower% changeNote to forecastsProfit attributable to owners of parentProfit attributable to owners of parentBasic earnings per share (Yen)Basic earnings per share (Yen)Note to consolidated forecastsCorrection of financial forecast from the most recent financial forecastCorrection of financial forecast from the most recent financial forecast3. 2022 12113120222022 12———————–11,8025,648881375900385638242———————-70.1526.61292020 3 311Forecast-Notes, Quarterly-Material changes in subsidiaries during this period changesin scope of consolidations resulting from change in subsidiariesNotes, Quarterly-Applying of specific accounting of the consolidated quarterlyfinancial statementsNotes, Quarterly-Changes in accounting policies and accounting estimatesretrospective restatementMaterial changes in subsidiaries during this period (Changes in scope ofconsolidations resulting from change is subsidiaries)Material changes in subsidiaries during this period (Changes in scope ofconsolidations resulting from change is subsidiaries)OthersMaterial changes in subsidiaries during this period (Changes in scopeof consolidations resulting from change is subsidiaries)Material changes in subsidiaries during this period (Changes inscope of consolidations resulting from change is subsidiaries)Number of subsidiaries newly consolidatedName of subsidiaries newly consolidatedNumber of subsidiaries excluded from consolidationName of subsidiaries excluded from consolidationNote to material changes in subsidiaries during this periodNote to material changes in subsidiaries during this periodApplying of specific accounting of the consolidated quarterly financial statementsApplying of specific accounting of the consolidated quarterly financialstatementsOthersApplying of specific accounting of the consolidated quarterly financialstatementsApplying of specific accounting of the consolidated quarterlyfinancial statementsNote to applying of specific accounting of the consolidated quarterlyfinancial statementsNote to applying of specific accounting of the consolidatedquarterly financial statementsChanges in accounting policies, accounting estimates and retrospectiverestatementChanges in accounting policies, accounting estimates and retrospectiverestatementOthersChanges in accounting policies, accounting estimates andretrospective restatementChanges in accounting policies based on revisions of accountingstandardChanges in accounting policies other than ones based onrevisions of accounting standardChanges in accounting estimatesRetrospective restatementNote to changes in accounting policies, accounting estimates andretrospective restatementMar 2022Mar 2022———–Mar 2022trueNote to changes in accounting policies, accounting estimates andretrospective restatementP.82.3Notes, Quarterly-Number of issued and outstanding shares common stockMar 2022Dec 2021Mar 2021Number of issued and outstanding shares (common stock)Number of issued and outstanding shares (common stock)OthersNumber of issued and outstanding shares (common stock)Number of issued and outstanding shares at the end of fiscal year(including treasury stock)Number of treasury stock at the end of fiscal yearAverage number of sharesNote to number of issued and outstanding shares (common stock)Note to number of issued and outstanding shares (common stock)-9,664,327569,4689,094,8649,664,327569,4489,095,035This information is a summary of the earnings report. It does not contain all details included in the earnings report disclosed in Japanese.